Page last updated: 2024-10-25

deferoxamine and Hepatitis B, Chronic

deferoxamine has been researched along with Hepatitis B, Chronic in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zou, DM1
Rong, DD1
Zhao, H1
Su, L1
Sun, WL1

Other Studies

1 other study available for deferoxamine and Hepatitis B, Chronic

ArticleYear
Improvement of chronic hepatitis B by iron chelation therapy in a patient with iron overload: A case report.
    Medicine, 2017, Volume: 96, Issue:52

    Topics: Adult; Chelation Therapy; Deferoxamine; Ferritins; Hepatitis B Surface Antigens; Hepatitis B, Chroni

2017